150 results
Page 3 of 8
8-K
EX-10.1
4vj7ltezhta usdklzn3
18 Feb 20
Entry into a Material Definitive Agreement
6:39am
8-K
EX-10.2
ufejsod
18 Feb 20
Entry into a Material Definitive Agreement
6:39am
8-K
EX-10.3
4pgpwhq x4v4a
13 Jan 20
Entry into a Material Definitive Agreement
6:19am
8-K
EX-10.1
4qlcks8
13 Jan 20
Entry into a Material Definitive Agreement
6:19am
8-K
EX-10.2
3hfhhmjrine zk7
13 Jan 20
Entry into a Material Definitive Agreement
6:19am
8-K
EX-10.3
8owifk6te5n
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-10.2
050pw1n0nu
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-10.1
eg8uxi0p7koa7m
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-10.4
vfy d5iv1nzdca
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-10.5
k6c 64msm97kl3mmu
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-10.2
9qpb3
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-10.1
mykxjpf 662v
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am